Bemnifosbuvir/Ruzasvir (BEM/RZR) Achieved its Primary Endpoint of Statistical Non-inferiority Compared to Sofosbuvir/Velpatasvir (SOF/VEL; Epclusa®), a Standard-of-Care, in First-Ever [...] Read more »
New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome
- Advanced analytical methods integrating clinical trial and real-world data address key evidence gaps in rare, difficult-to-treat blood cancers
- Read more »
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome
- Clinically meaningful improvements in skin symptoms reported as early as week 4 and sustained over the 48-week study period
- Data presented at [...] Read more »
Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL
PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the treatment of relapsed or [...] Read more »
Dia Mundial do Vape 2026: Uma Mudança, Todos Ganham
BRUXELAS, May 30, 2026 (GLOBE NEWSWIRE) -- Hoje, vapers, ex-fumantes e defensores da redução de danos marcam o Read more »
World Vape Day 2026: One Switch – Everyone Wins
BRUSSELS, May 30, 2026 (GLOBE NEWSWIRE) -- Today, vapers, former smokers, and harm reduction advocates mark Read more »
Hanmi Pharmaceutical تتعاون مع Organon لتصدير علاجات مركبة إلى جنوب شرق آسيا
Shin Hae-gon (إلى [...] Read more »
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia
Shin Hae-gon (right), Head of Overseas Sales at Hanmi Pharmaceutical, and Andreas Daugaard Jørgensen (left), Managing Director, Organon Asia Pacific Cluster, met at Organon’s Malaysia office to [...] Read more »
Countdown Grant Explores How Cells Remove Damaged Mitochondria — Opening New Possibilities Across Parkinson’s, Chronic Disease, Rare Disease, and Aging
ATLANTA, May 15, 2026 (GLOBE NEWSWIRE) -- Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr. Elias Adriaenssens at the Research [...] Read more »
تعلن مجموعة neurocare AG عن ترخيص تسويق الأجهزة الطبية (MDMA) لبيع أجهزة التحفيز المغناطيسي عبر الجمجمة (TMS) في المملكة العربية السعودية
ميونخ، ألمانيا والرياض، المملكة [...] Read more »